To the Point
Expiring Patents, Drug Prices and the Hazy Market for Generics
Patents are about to expire on two of the world's best-selling prescription drugs. Prices for cholesterol-fighter Lipitor and the blood-thinner Plavix are likely to drop by 80 percent when they're replaced by generics. But that's not all. The drug industry will be faced with an unprecedented wave of expiring patents in the next few years.
By Warren Olney • • 1 min readPatents are about to expire on two of the world's best-selling prescription drugs. Prices for cholesterol-fighter Lipitor and the blood-thinner Plavix are likely to drop by 80 percent when they're replaced by generics. But that's not all. The drug industry will be faced with an unprecedented wave of expiring patents in the next few years. What will the expiration of patents on many other drugs mean for Big Pharma? How is the industry fighting back? Will consumers get the benefits they deserve?
The full episode
2 of 2
While Congress Fiddles, Big Pharma Is in for Big Changes- 0:00President Obama Urges Compromise…Again
- 23:42Expiring Patents, Drug Prices and the Hazy Market for GenericsYou’re reading this
The full episode
2 of 2While Congress Fiddles, Big Pharma Is in for Big Changes- 0:00President Obama Urges Compromise…Again
- 23:42Expiring Patents, Drug Prices and the Hazy Market for GenericsYou’re reading this